SQUINTO STEPHEN P

CIK 00012319546 companiesCHESHIRE, CT

SEC Profile

Transactions

Companies

Filings

CIK

0001231954

Recent Transactions

50 trades

Award
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2022-05-19+15,318→ 15,318 total
Award
SpringWorks Therapeutics, Inc.
Common Stock
2022-05-19+4,818→ 131,652 total
Award
Compass Therapeutics, Inc.$CMPX
Stock Option (Right to Buy)
2022-02-18+30,000→ 30,000 total
Award
SpringWorks Therapeutics, Inc.
Common Stock
2021-05-20+1,106→ 126,834 total
Award
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2021-05-20+6,998→ 6,998 total
Sale
SpringWorks Therapeutics, Inc.
Common Stock
2021-04-28$76.20/sh−19,231→ 125,728 total
Sale
SpringWorks Therapeutics, Inc.
Common Stock
2021-04-27$75.05/sh−201→ 144,959 total
Award
Chemomab Therapeutics Ltd.$CMMB
Option to Purchase American Depositary Shares
2021-04-19+23,768→ 23,768 total
Sale
SpringWorks Therapeutics, Inc.
Common Stock
2021-04-15$75.01/sh−1,057→ 145,160 total
Sale
SpringWorks Therapeutics, Inc.
Common Stock
2021-04-14$75.08/sh−511→ 146,217 total
Award
Compass Therapeutics, Inc.$CMPX
Stock Option (Right to Buy)
2020-08-06+30,000→ 30,000 total
Award
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2020-05-20+7,464→ 7,464 total
Award
SpringWorks Therapeutics, Inc.
Common Stock
2020-03-12+20,000→ 20,000 total
Award
Passage BIO, Inc.$PASG
Employee Stock Option (Right to Buy)
2020-02-27+185,776→ 185,776 total
Award
Passage BIO, Inc.$PASG
Director Stock Option (Right to Buy)
2020-02-27+33,836→ 33,836 total
Conversion
SpringWorks Therapeutics, Inc.
Series B Convertible Preferred Stock
2019-09-17−1,053,204→ 0 total
Conversion
SpringWorks Therapeutics, Inc.
Common Stock
2019-09-17+6,078,103→ 6,078,103 total
Conversion
SpringWorks Therapeutics, Inc.
Common Stock
2019-09-17+1,053,204→ 7,131,307 total
Conversion
SpringWorks Therapeutics, Inc.
Series A Convertible Preferred Stock
2019-09-17−6,078,103→ 0 total
Purchase
SpringWorks Therapeutics, Inc.
Common Stock
2019-09-17$18.00/sh+275,000→ 7,406,307 total
Award
SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
2019-09-12+29,983→ 29,983 total
Award
SpringWorks Therapeutics, Inc.
Series A Convertible Preferred Stock
2019-03-29+40,000,000→ 6,078,103 total
Award
SpringWorks Therapeutics, Inc.
Series B Convertible Preferred Stock
2019-03-29+6,931,142→ 1,053,204 total
Award
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2017-10-08+9,000→ 9,000 total
Award
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2016-08-24+9,000→ 9,000 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2014-10-27$78.88/sh+3,075→ 112,418 total
Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2014-10-27$188.36/sh−3,841→ 108,577 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2014-10-27$42.66/sh−2,475→ 0 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2014-10-27$42.66/sh+2,475→ 109,343 total
Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2014-10-27$189.00/sh−2,069→ 106,508 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2014-10-27$78.88/sh−3,075→ 7,737 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2014-10-03$42.66/sh−10,025→ 2,475 total
Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2014-10-03$174.95/sh−4,925→ 106,868 total
Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2014-10-03$169.95/sh−5,100→ 111,793 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2014-10-03$42.66/sh+10,025→ 116,893 total
Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2014-09-24$159.50/sh−76→ 106,868 total
Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2014-08-04$157.42/sh−1,662→ 106,944 total
Award
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2014-02-28+4,000→ 108,606 total
Award
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2014-02-28$176.80/sh+49,200→ 49,200 total
Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2014-02-10$167.31/sh−1,635→ 101,308 total
Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2014-02-07$157.51/sh−20→ 102,943 total
Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2014-02-07$155.55/sh−1,600→ 102,963 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2014-02-06−3,800→ 0 total
Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2014-02-06$155.11/sh−3,800→ 94,818 total
Award
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2014-02-06+9,745→ 104,563 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2014-02-06$93.83/sh+3,800→ 98,618 total
Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2014-02-04$155.00/sh−29,637→ 94,818 total
Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2014-02-04$153.63/sh−3,200→ 99,016 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2014-02-04$42.66/sh+6,250→ 109,842 total
Exercise/Conversion
ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2014-02-04−6,250→ 0 total

Companies

Recent Filings

Address

C/O ALEXION PHARMACEUTICALS INC 352 KNOTTER DRIVE

CHESHIRE, CT, 06410

View on SEC.gov